StemGen, Inc. SGNI
OTC PK
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 20.00K | 20.00K | 15.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.00K | 20.00K | 15.00K | -- | -- |
| Cost of Revenue | 12.00K | 12.90K | 5.80K | -- | -- |
| Gross Profit | 8.00K | 7.10K | 9.20K | -- | -- |
| SG&A Expenses | 292.20K | 175.60K | 185.70K | -- | -- |
| Depreciation & Amortization | 116.00K | 116.70K | 116.70K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 420.30K | 305.40K | 308.30K | -- | -- |
| Operating Income | -400.30K | -285.40K | -293.30K | -- | -- |
| Income Before Tax | -536.60K | -449.00K | -482.40K | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.54 | -0.45 | -0.48 | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -536.60K | -449.00K | -482.40K | -- | -- |
| EBIT | -400.30K | -285.40K | -293.30K | -- | -- |
| EBITDA | -284.20K | -168.60K | -176.60K | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -- | -- |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -- | -- |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -- | -- |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -- | -- |
| Average Basic Shares Outstanding | 182.40M | 182.40M | 182.40M | -- | -- |
| Average Diluted Shares Outstanding | 182.40M | 182.40M | 182.40M | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |